NG

Neeraj Gupta

Active Director Director DIN 01214836
DIN 01214836 First appointment Feb 1994 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since Feb 1994
Shareholding value •••• Premium profile

About Neeraj Gupta

Data last updated:

Neeraj Gupta is a Director at Imperial Life Sciences Private Limited (since 2006), Director at Genes 2Me Private Limited (since 2019) and Director at Ils Foundation (since 2015), and holds 1 more current directorship. The companies operate in Healthcare, Pharma and Consumer Electronics & Durables. The 4 current companies with reported revenue have a combined latest revenue of ₹98.19 Cr; the largest is Imperial Life Sciences Private Limited at ₹76.20 Cr (FY 2025). Earlier, Neeraj Gupta was a Director at Swernim Electronics Private Limited (2022–2024) and Director at Innovative Life Discoveries Private Limited (2009–2011) and 1 more.

DIN 01214836
Primary Designation Director
Industry Healthcare
First Appointment 04 Feb 1994
Oldest Company Age 34 yrs
Largest company Imperial Life Sciences Private Limited · ₹76.20 Cr (FY 2025)
Combined revenue ₹98.19 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jun 20062006₹76.20 Cr (FY 2025)Active
Genes 2Me Private Limited U73200DL2019PTC354174
Director23 Aug 20192019₹21.72 Cr (FY 2025)Active
Ils Foundation U85100DL2015NPL278960
Director13 Apr 20152015₹26.1 Lakh (FY 2025)Active
Imperial Biomedic Pvt Ltd U51397CH1992PTC012504
Director04 Feb 19941992₹6,440 (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Swernim Electronics Private Limited U32109DL1996PTC078438
Director27 Dec 20221996₹92.1 Lakh (FY 2024)Active
Director19 Jan 20092009Active
Genes 2Me Llp AAF-6734
Designated Partner10 Feb 20162016Converted To Cmp And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Imperial Life Sciences Private Limited
Imperial Biomedic Pvt Ltd
Genes 2Me Private Limited
Ils Foundation
Premium access

Shareholding and investment profile for Neeraj Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Gupta

Neeraj Gupta currently holds 4 directorships: Imperial Life Sciences Private Limited (Director, since 17 Jun 2006, revenue ₹76.20 Cr (FY 2025)); Genes 2Me Private Limited (Director, since 23 Aug 2019, revenue ₹21.72 Cr (FY 2025)); Ils Foundation (Director, since 13 Apr 2015, revenue ₹26.1 Lakh (FY 2025)); Imperial Biomedic Pvt Ltd (Director, since 04 Feb 1994, revenue ₹6,440 (FY 2023)).

Neeraj Gupta was first appointed on 04 Feb 1994 as Director at Imperial Biomedic Pvt Ltd. The most recent appointment on record is 27 Dec 2022 at Swernim Electronics Private Limited.

The 4 current companies of Neeraj Gupta that report revenue have a combined latest revenue of ₹98.19 Cr: Imperial Life Sciences Private Limited ₹76.20 Cr (FY 2025); Genes 2Me Private Limited ₹21.72 Cr (FY 2025); Ils Foundation ₹26.1 Lakh (FY 2025); Imperial Biomedic Pvt Ltd ₹6,440 (FY 2023).

Neeraj Gupta held 3 earlier board appointments: Swernim Electronics Private Limited (Director, 27 Dec 2022 to 19 Aug 2024); Innovative Life Discoveries Private Limited (Director, 19 Jan 2009 to 20 Jun 2011); Genes 2Me Llp (Designated Partner, from 10 Feb 2016).

The current boards of Neeraj Gupta's companies include Prem Lata Gupta (Imperial Life Sciences Private Limited), Ritu Gupta (Imperial Life Sciences Private Limited), Suresh Kumar Gupta (Imperial Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available